Clinical Trial Update: Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Recombinant Factor VIIa for intracerebral hemorrhage is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Drugs mentioned

• Recombinant Factor VIIa (recombinant activated factor VII)

Snippet

Sponsor: Joseph Broderick, MD | Conditions: Intracerebral Hemorrhage | Phase 3 | Status: ACTIVE_NOT_RECRUITING